BioMarin Pharmaceutical
BMRN
#1952
Rank
C$15.04 B
Marketcap
C$77.85
Share price
-0.54%
Change (1 day)
1.90%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2026 (TTM): C$0.52 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are C$3.24 Billion. In 2025 the company made an earning of C$0.67 Billion a decrease over its 2024 earnings that were of C$0.75 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.52 B-21.81%
2025 C$0.67 B-10.94%
2024 C$0.75 B187.31%
2023 C$0.26 B26.07%
2022 C$0.20 B-298.51%
2021 -C$0.11 Billion78.04%
2020 -C$59.21 Million-55.36%
2019 -C$0.14 Billion-33.56%
2018 -C$0.2 Billion297.78%
2017 -C$50.19 Million-95.68%
2016 -C$1.17 Billion437.12%
2015 -C$0.22 Billion23.91%
2014 -C$0.18 Billion-29.25%
2013 -C$0.25 Billion49.23%
2012 -C$0.17 Billion171.11%
2011 -C$61.03 Million103.01%
2010 -C$30.07 Million-3903.54%
2009 C$0.79 M-98.31%
2008 C$46.75 M-189.7%
2007 -C$52.13 Million51.02%
2006 -C$34.52 Million-61.58%
2005 -C$89.83 Million-56.59%
2004 -C$0.21 Billion95.13%
2003 -C$0.11 Billion12.09%
2002 -C$94.6 Million73.19%
2001 -C$54.63 Million18.32%
2000 -C$46.17 Million19.65%
1999 -C$38.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
C$10.71 B 1,886.15%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-C$0.76 Billion-239.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-C$0.16 Billion-128.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-C$38.39 Million-107.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$0.26 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
C$0.39 B-26.47%๐Ÿ‡บ๐Ÿ‡ธ USA